Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 136.60
Bid: 136.40
Ask: 137.00
Change: -0.80 (-0.58%)
Spread: 0.60 (0.44%)
Open: 137.60
High: 137.60
Low: 135.80
Prev. Close: 137.40
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of Mouchel Consulting to WSP Global

12 Oct 2016 07:00

RNS Number : 3163M
Kier Group PLC
12 October 2016
 

 

Disposal of Mouchel Consulting to WSP Global Inc.  

 

Kier Group plc ("Kier"), a leading property, residential, construction and services group, is pleased to announce that it has completed the disposal of Mouchel Consulting to WSP Global Inc. ("WSP") for a total consideration of £75m, satisfied in cash.

 

Mouchel Consulting, acquired in June 2015 as part of Kier's acquisition of Mouchel, provides engineering, environmental and asset management consultancy services, principally to infrastructure markets. On 4 July, Kier announced that it was undertaking an evaluation of the strategic options for the Mouchel Consulting business including a possible disposal.

 

For the financial year ended 30 June 2016, Mouchel Consulting reported revenue of £125m generating an operating profit contribution of £8m and a profit before tax of £5m. The gross assets of the company, the subject of the disposal, were £29m at 30 June 2016.

 

The disposal is expected to result in an immediate profit of approximately £40m, subject to post-completion adjustments. The net disposal proceeds will be retained by Kier for future investment purposes and to further reduce debt, supporting Kier's Vision 2020 target of net debt to EBITDA ratio of less than 1x which was achieved ahead of schedule in 2016.

 

Haydn Mursell, chief executive of Kier, commented: "Having completed the integration of Mouchel, we are well progressed with the simplification of our portfolio of businesses. The disposal of Mouchel Consulting continues this process and provides increased capital to focus on the opportunities across our core businesses which will underpin the Group's future growth."

 

- E N D S -

 

Enquiries:

 

Faeth Birch / Daniela Fleischmann Finsbury +44 (0)20 7251 3801

Kier press office +44 (0)1767 355903

Louise Turner-Smith, Head of Investor Relations, Kier +44 (0)7976 790012

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISGGGAAUUPQUAP
Date   Source Headline
6th Oct 20232:34 pmRNSAnnual Financial Report
2nd Oct 202311:15 amRNSTotal Voting Rights
22nd Sep 20232:00 pmRNSDirector/PDMR Shareholding
22nd Sep 202310:09 amRNSHolding(s) in Company
20th Sep 20231:42 pmRNSHolding(s) in Company
20th Sep 20231:39 pmRNSDirector/PDMR Shareholding
15th Sep 20234:06 pmRNSDirector/PDMR Shareholding
14th Sep 20232:36 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSFull Year Results for the year ended 30 June 2023
8th Sep 20233:45 pmRNSHolding(s) in Company
4th Sep 20233:37 pmRNSAcquisition of rail assets for £9.6 million
31st Aug 202310:35 amRNSNotification of change of director’s details
30th Aug 20233:06 pmRNSHolding(s) in Company
23rd Aug 20237:00 amRNSNotice of FY23 Results and Presentations
21st Aug 20233:16 pmRNSDirector/PDMR Shareholding
28th Jul 202310:07 amRNSHolding(s) in Company
26th Jul 202311:06 amRNSHolding(s) in Company
20th Jul 20236:03 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFull Year 2023 Trading Update
3rd Jul 20233:17 pmRNSTotal Voting Rights
21st Jun 20234:45 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amRNSHS2 Site Visit
19th May 20231:07 pmRNSDirector/PDMR Shareholding
28th Apr 202311:03 amRNSDirector/PDMR Shareholding
20th Apr 20233:32 pmRNSDirector/PDMR Shareholding
4th Apr 20233:31 pmRNSDirectorate Change
30th Mar 20233:25 pmRNSDirectorate Change
27th Mar 20234:30 pmRNSHolding(s) in Company
21st Mar 20234:16 pmRNSDirector/PDMR Shareholding
17th Mar 202310:33 amRNSDirector/PDMR Shareholding
16th Mar 20234:38 pmRNSHolding(s) in Company
10th Mar 20234:06 pmRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNSHalf-year Report
28th Feb 20234:59 pmRNSHolding(s) in Company
20th Feb 20234:30 pmRNSDirector/PDMR Shareholding
13th Feb 20234:50 pmRNSHolding(s) in Company
1st Feb 202310:12 amRNSTotal Voting Rights
25th Jan 202311:01 amRNSHolding(s) in Company
20th Jan 202310:00 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update
5th Jan 202310:16 amRNSChange of Director's Details
3rd Jan 202311:05 amRNSTotal Voting Rights
3rd Jan 202311:02 amRNSBlock listing Interim Review
20th Dec 20223:26 pmRNSDirector/PDMR Shareholding
15th Dec 20225:15 pmRNSHolding(s) in Company
1st Dec 202210:04 amRNSTotal Voting Rights
22nd Nov 20222:44 pmRNSDirector/PDMR Shareholding
18th Nov 202211:30 amRNSDirector/PDMR Shareholding
17th Nov 20224:51 pmRNSResult of AGM
17th Nov 20227:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.